The Valley Desk

NCT05384626 · Interventional trial

A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

Overall registry status Recruiting

Phase 1 · Phase 2

Conditions Locally Advanced Solid Tumor, Metastatic Solid Tumor

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov